Pertussis (Whooping Cough) Market Growth And Forecast Study To 2016 Pertussis (Whooping Cough) - Pipeline Review, H2 2

Pertussis ( Whooping Cough ) Market Size , Share , Analysis , Forecast , Industry Strategy , Opportunity , Trends , Insights , Growth , Price , Research Survey , Segment , Outlook and Challenges Report To 2016

Pertussis ( Whooping Cough ) Market Size , Share , Analysis , Forecast , Industry Strategy , Opportunity , Trends , Insights , Growth , Price , Research Survey , Segment , Outlook and Challenges Report To 2016

Market Reports Center latest Pharmaceutical and Healthcare disease pipeline guide Pertussis ( Whooping Cough ) – Pipeline Review , H2 2016 , provides an overview of the Pertussis ( Whooping Cough ) ( Infectious Disease ) pipeline landscape .
Pertussis , also known as whooping cough , is a highly contagious respiratory disease . It is caused by the bacterium Bordetella pertussis . Symptoms include runny nose , nasal congestion , sneezing , red , watery eyes and dry cough . Treatment includes antibiotics .
Report Highlights
Market Reports Center Pharmaceutical and Healthcare latest pipeline guide Pertussis ( Whooping Cough ) – Pipeline Review , H2 2016 , provides comprehensive information on the therapeutics under development for Pertussis ( Whooping Cough ) ( Infectious Disease ), complete with analysis by stage of development , drug target , mechanism of action ( MoA ), route of administration ( RoA ) and molecule type . The guide covers the descriptive pharmacological action of the therapeutics , its complete research and development history and latest news and press releases .
To Get Complete Report : https :// marketreportscenter . com / reports / 490764 / pertussiswhooping-cough-pipeline-review-h2-2016
The Pertussis ( Whooping Cough ) ( Infectious Disease ) pipeline guide also reviews of key players involved in therapeutic development for Pertussis ( Whooping Cough ) and features dormant and discontinued projects . The guide covers therapeutics under Development by Companies / Universities / Institutes , the molecules developed by Companies in Pre-Registration , Filing rejected / Withdrawn , Phase III , Phase II , Phase I , IND / CTA Filed , Preclinical and Discovery stages are 1 , 1 , 12 , 3 , 5 , 1 , 9 and 2 respectively . Similarly , the Universities portfolio in Phase II , Phase I , Preclinical and Discovery stages comprises 1 , 1 , 1 and 3 molecules , respectively .
Pertussis ( Whooping Cough ) ( Infectious Disease ) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios , enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage . The guide is built using data and information sourced from Global Markets Direct ’ s proprietary